In observance of the Presidents Day, the National Scleroderma Foundation’s national office will be closed Monday, Feb. 20. We look forward...
CEO Mary J. Wheatley shares a message reflecting on the 25 years of support the National Scleroderma Foundation has provided to...
The National Scleroderma Foundation encourages appropriate vaccines and treatments to protect individuals within the scleroderma community from the serious complications that...
Eight new and established researchers receive grant awards DANVERS, MASSACHUSETTS – On Thursday, Feb. 2, the National Scleroderma Foundation announced its...
We are grateful to our partner HealthWell Foundation for launching a new Patient Assistance Program for SSc-ILD! Learn more at HealthWell’s...
Our 2022 Annual Report is now available on our website! This report serves as a summary of the Foundation’s activities over...
National Scleroderma Foundation CEO, Mary J. Wheatley, IOM, CAE, recently reviewed key mission metrics with Foundation stakeholders. Watch this quarter’s update...
We’re excited to meet with you in-person or virtually for the 2023 National Scleroderma Conference! We’re busy working behind the scenes...
On Monday, Jan. 16, the National Scleroderma Foundation joins the rest of nation in honoring the life of Dr. Martin Luther...
